|
Post by lakers on May 6, 2017 12:45:26 GMT -5
Once upon a time, AMD built its own microprocessors in company-owned factories. A long-standing manufacturing research partnership with IBM helped to keep those chipmaking operations going. But things have changed. Investment groups from Abu Dhabi started building ownership in AMD in 2007, and right at the darkest days of the 2008 financial crisis, that relationship led to AMD's manufacturing operations spinning off into a joint venture called GlobalFoundries. While the rest of the world seemed stopped in its financial tracks, AMD shares surged 30% in a single day on this news. GlobalFoundries still counts AMD as its largest customer, but now operates as a completely separate business with plenty of supply contracts with other chip designers. The manufacturing spinoff gave AMD a fighting chance to survive as Intel retook its throne while market conditions started to shift away from PC systems. The balance sheet lightened immensely when the GlobalFoundries separation closed in 2010. AMD used the funds from that deal to pay down debt balances, and annual interest payments took a deep dive. Without the GlobalFoundries transaction, AMD probably wouldn't have survived this far. So AMD is now a fab-less chip designer, and better off for it. www.fool.com/investing/2017/04/15/5-things-you-didnt-know-about-advanced-micro-devic.aspxThe new strategy splits off AMD's manufacturing plants into a new joint venture with two investment arms of the United Arab Emirates' government. Eleven months ago, the Mubadala Group injected $614 million into AMD's anemic coffers and took an 8% stake in the company. The Arab investors are picking up another 58 million freshly minted AMD shares for $314 million, growing their stake to 19%. At the same time, the Advanced Technology Investment Company of Abu Dhabi takes on $1.2 billion of AMD's long-term debt and contributes at least $3.6 billion to the new Foundry Company's bank accounts. www.fool.com/investing/value/2008/10/07/amd-splits-off.aspxAlthough GlobalFoundries has been expected to eventually move to 7-nanometer chip production, it was significant because it shows that the company and its backers — the government of Abu Dhabi — are looking at making significant investments at the Fab 8 site in the coming years after spending $12 billion since breaking ground on the site in 2009. m.timesunion.com/business/article/GlobalFoundries-plans-multi-billion-investment-9224994.phpAccording to a market filing on Saturday, Mubadala sold shares worth $613.4m on the public market in the Nasdaq-listed multinational known for developing computer processors and related technologies. Mubadala said the sale equated to 45 million AMD shares – nearly a third of the UAE company’s 142 million shareholding. The company said it planned to hold the remaining 97 million shares it owns in AMD, meaning even after the sale it will remain its largest single shareholder. It is followed by the US-based asset management company BlackRock, which currently owns an 8.69 per cent stake. AMD, formerly known as Advanced Micro Devices, is the second largest supplier in the world of standard computer microprocessors after its main rival Intel. Mubadala first invested in AMD back in 2007. The company said that it had decided to realise some of its investment in the company and would use the cash for further opportunistic investment. m.thenational.ae/business/technology/mubadala-sells-600m-plus-worth-of-shares-in-computer-company-amdThis could happen to pharmaceutical if Abu Dhabi sovereign fund and Mubadala like the Afrezza total medical cost savings.
|
|
|
Post by lakers on May 6, 2017 12:27:11 GMT -5
just throwing it out in the atmosphere. IF, IF, any of this is true (The sale to Dubai. www.screencast.com/t/WGgyVVcy)If "the market" at some point concludes "MNKD can survive," Where do you see the adjustment in the market cap going? MNKD share Price was at $2.50 three months ago. "Understandably, there are many parties who are waiting to see if Afrezza is adopted by the US and will be around. There are also many parties who want to be the first to introduce Afrezza in their regions." If "the market" at some point concludes "MNKD can survive," This will open the floodgates for multiple regional partners not only for A but also for inhaled TS pipeline - snowball, bootstrap effect. Take care of the patients first, pps will follow.
|
|
|
Post by lakers on May 6, 2017 11:15:04 GMT -5
On 4/1/17, Our international expansion focuses on those countries which have a less prolonged regulatory pathway given our US FDA approval. We are preparing filings for Brazil, Canada, Mexico, Australia, MENA, and the UAE. We are also evaluating EMA and other regions. Understandably, there are many parties who are waiting to see if Afrezza is adopted by the US and will be around. There are also many parties who want to be the first to introduce Afrezza in their regions. While there are ongoing discussions, our corporate policy is not to announce any material developments until there is definitive progress (translated to legally bounded agreements). Read more: mnkd.proboards.com/thread/6408/mnkd-state-union?page=19#ixzz4gJeGLXyP$10M Notes due in July was not addressed. Hiring continues. The need to extend the runway by at least 12 mos. That's $110M needed. Media Mktg continues. Trials will start. CTO on insulin procurement with AMPH in the next few years was filed 4/26/17 valid until 12/31/23. Why hide if you are on death bed? files.shareholder.com/downloads/AMDA-22AIJ9/4425746023x0xS9999999997%2D17%2D5733/899460/filing.pdfexcluded information from the following exhibit(s) will not be released to the public for the time period(s) specified: Exhibit 10.33 through December 31, 2023 10.33** Second Amendment to Supply Agreement, dated November 9, 2016, by and between MannKind and Amphastar Pharmaceuticals, Inc. Confidential treatment has been granted with respect to certain portions of this exhibit. Omitted portions have been filed separately with the SEC. files.shareholder.com/downloads/AMDA-22AIJ9/4425746023x0xS1193125%2D17%2D85519/899460/filing.pdfThe funding potentially could come from international expansion. 20% of UAE population has diabetes in 2015. UAE Ministry of Health shocked by report on diabetes Nick Webster Apr 07, 2016 m.thenational.ae/uae/health/uae-ministry-of-health-shocked-by-report-on-diabetesDiabetes in the United Arab Emirates: Crisis or Opportunity - UnitedHealth Group By 2020, an estimated 32 percent of the adult population (age 20-79), including both UAE nationals and expatriates, may have diabetes or prediabetes at a ... The prevalence of type 2 diabetes in the UAE is amongst the highest in the world with some estimates putting it in the top five. Globally, 6.4 percent of the population between 20 and 79 years of age has diabetes.* In the UAE, more than double that percentage has diabetes — about 13 percent, or nearly one in eight people in the 20-79 age group.8 The prevalence of type 2 diabetes is estimated to be similar among male and female adults, with about 13 percent of men age 20-79 with type 2 diabetes (including both diagnosed and undiagnosed cases) and about 12 percent of women9. Another estimated 14 percent of the population has prediabetes, meaning they are at grave risk of developing the disease. Women in the UAE are more likely to have prediabetes than men.10 www.unitedhealthgroup.com/~/media/UHG/PDF/2010/UNH_WorkingPaperDiabetesUAE.ashx?la=en
|
|
|
Post by lakers on May 6, 2017 11:07:05 GMT -5
|
|
|
Post by lakers on May 5, 2017 11:48:17 GMT -5
Keep in mind, Charles Mattocks is friends with Dr. Oz. He might get on to talk about his show and possibly Afrezza. The fact still is that most diabetics have no clue that Afrezza is out there. It could be a big boost, Afrezza still can be a success. By cc1972. Imagine CM lands on CBS 60 mins, ABC 20/20, NBC 48 hrs talking about his endeavors to reverse diabetes. Priceless and help Afrezza Reach the largest audience possible for free! Each career move, Charles Mattocks has made has been in keeping with his desire to touch lives in a positive way. Inspired by his uncle, the late reggae legend Bob Marley, Charles dared to dream big. His need to create meals that were tasty, nutritious, and affordable led to his career as "The Poor Chef". Multiple appearances on The Today Show, Good Morning America,Fox News The Talk, Martha Stewart,CNN & Dr. Oz gave him the opportunity to share what he had learned CBS TV about feeding a family for less money. Then came devastating news; Charles was diagnosed with type 2 diabetes. He was determined to save his life and knew he had to help others do the same. "The Diabetic You" documentary, website, and movement came out of that determination to educate and inspire people around the world. He is doing just that! From appearances on CNN, The Today Show, Anderson Cooper, Good Morning America and scores of other TV shows and radio programs across the country. From interviews in Huffington Post, Diabetes Health, Examiner, his regular blog on the Dr. Oz website, and more, the world is learning about A tireless advocate for diabetics everywhere, Charles Mattocks, is determined to help stem the tide of this deadly disease. Charles is also wrapping up his diabetes documentary entitled “The Diabetic You” and has just shot and is selling the first diabetes reality TV show entitled “Reversed”. Charles’ new Children's Book is sure to educate and inspire this year as he travels around the country to promote it. He also works with the American Diabetes Association and just concluded writing a new cookbook released in June 2014. Charles is also a contributor to NBC/BLK where he talks candid about diabetes. Charles has recently completed a documentary on this debilitating disease, entitled "Trial By Fire".The film has won a total of seven award around the world and Charles won best director. Celebrity chef & Worldwide diabetes advocate Each career move Celebrity Chef Mattocks has made has been in keeping with his desire to touch lives in a positive way. Inspired by his uncle, the late Bob Marley, Mattocks dared to dream big. After giving a stunning performance in the title role of the Emmy nominated "The Summer of Ben Tyler" Mattocks could have continued as a successful actor. Instead this single dad decided the Hollywood lifestyle was not the best for his young son and moved across the country. www.indiewire.com/2016/12/cnn-fox-news-msnbc-nbc-ratings-2016-winners-losers-1201762864/It is estimated that Discovery Life is available in approximately 45 million to 50 million homes. That represents availability in between 40% and 45% of the overall market. In 2016 Discovery Life channel ranked 97th in viewership with 89,000 viewers. This was a 7% increase from 83,000 viewers during 2015.
|
|
|
Post by lakers on May 3, 2017 2:46:54 GMT -5
NFL players fight pain with medical marijuana: ‘Managing it with pills was slowly killing me’ www.washingtonpost.com/sports/redskins/nfl-players-fight-pain-with-medical-marijuana-managing-it-with-pills-was-slowly-killing-me/2017/05/02/676e4e62-2e80-11e7-9534-00e4656c22aa_story.html?tid=hybrid_experimentrandom_2_na-amp&utm_term=.2acffa2d0ea1CW Hemp specializes in cannabis that is rich in cannabidiol (CBD) that the ex-players were told acts acts much differently than marijuana as most people know it. The company’s roots are in helping cancer patients undergoing radiation and chemotherapy, and it began making headlines when children with epilepsy saw a dramatic drop in the number of seizures they experienced after taking CBD. The plant used to be called “hippie’s disappointment,” Vijay Bachus, the company’s site director, told the former players, “because it wouldn’t get you high.” “It had high levels of CBD but low levels of THC. Nobody would be smoking it for recreational purposes,” he said, likening the THC levels to the amount of alcohol found in an O’Doul’s. THC — tetrahydrocannabinol — is the cannabinoid that produces the high that most associate with marijuana. CBD has some similar properties but not the psychoactivity and mood-altering effects. The DEA warned NFL doctors about drug laws While researchers have found that THC might have some benefits — particularly with pain, anxiety or nausea — the science behind CBD is not as robust. But recent studies have found evidence that it can be effective treating everything from epilepsy and cancer to heart disease, diabetes, anxiety and schizophrenia. It can also act as an anti- inflammatory and a neuroprotectant, raising hopes it may be valuable in treating and preventing head injuries. Research has found that CBD increases a molecule called anandamide, which reduces pain and increases the production of neurons in the hippocampus region of the brain, which can impact mood and anxiety. Compared with a placebo, the National Academies of Science, Medicine and Engineering found “strong evidence” that marijuana is effective at dealing with chronic pain. Twenty-nine states plus the District of Columbia have legalized medical marijuana; 22 of the NFL’s 32 teams play their home games in those jurisdictions. “I think in due time, the NFL is going to realize that CBD is not a performance-enhancing drug,” Ekuban said. “If anything, it helps with anxiety, helps with concentration, it helps with pain.”
|
|
|
Post by lakers on May 3, 2017 2:13:11 GMT -5
IR replied,
We are in a quiet period until our earnings call on May 10....please listen to the call. Some of your questions may be answered
|
|
|
Post by lakers on May 3, 2017 1:53:45 GMT -5
MannKind Sponsors New Diabetes Reality TV Show, 'Reversed' www.healthline.com/diabetesmine/mannkind-sponsors-reversed-reality-tv-show-diabetesWritten by Mike Hoskins Published on May 2, 2017 Strong Afrezza endorsement by Amy Tenderich and Mike Hoskins. Excerpts follow. Really, Diabetes Reality TV? Yup, Mattocks describes it as a docu-series reality show that is "part of his journey." Take a look at this video promo just released in late April. To be clear, this is not the first time a reality TV show has dabbled in life with diabetes -- from the MTV TruLife episode back in 2012 that featured three T1 PWDs, to a T1 teen mom, and the American Idol competition in 2015 featuring Adam Lasher, a T1 nephew of Carlos Santana. Apparently, even rap legend Dr. Dre (who lives with T2D himself) has been talking about creating his own D-related reality show, given his complication-ridden T2 that's led to him losing his vision. But Reversed does appear to be the first national reality show 100% dedicated to diabetes and its management. What you'll be watching is five PWDs in a house surrounded by beaches and palm trees at the Milbrooks Resort island retreat in exotic Montego Bay, Jamaica. In a recent podcast, Mattocks talked with three of the PWDs who participated in thes show -- two type 2s, and a T1 who just started on Afrezza after being on the show. Interestingly, during the 15-minute podcast, the trio talked about how they didn't expect the show to be as life-changing as it was, helping them acheive better D-management and health habits. One of the T2s named Jerome said it's "exactly what he needed" to change his mindset and since the show's production wrapped up, he has not only lost weight and felt better, but with help from his doctor he's managed to dramatically cut down his insulin intake and other medications. They all agreed the show wasn't keyed in on or overbearing on messages of weight loss, low-carb or plant-based eating, but rather about finding what works best for each of them in making healthier choices. The T1, a woman named Felice, spoke on the podcast about her 43 years with T1D and how she was "heading into the deep hole of D-burnout" before going on Reversed, and since then she's been able to change her attitude and perspective. She started Afrezza in mid-April, which she says has translated to only one basal injection per day instead of seven multiple daily injections, fewer hypos and much more stable BGs. These personal PWD accounts were certainly very convincing that the show has merit. Beyond this introductory season, Charles is pondering future options -- a live-recorded version, celebrity cast, and even going beyond diabetes into other health conditions. "We think we have something special here, and we do think we're going to be changing lives," he said Sponsored by Afrezza / MannKind Corp. As noted, MannKind is currently the show's sole sponsor, so they get fully play, including a display ad on the show's website with an image of the late Alfred Mann, who created the company and passed away in early 2016. MannKind's Chief Operational Officer Mike Castagna tells us that as sponsors, they have no involvement in the show's development or content. While one participant will be using and demonstrating Afrezza on the air, that wasn't a requirement and was not even intentional product placement. Castagna says they've created a storyboard for a commercial -- something that show coordinators say will be 1-minute long, rather than 30 seconds as the FDA usually mandates for pharma ads. (We mentioned this in our recent coverage of MannKind's wish to become "the Uber of diabetes.") Whether this helps MannKind's business with Afrezza is anyone's guess. But you can't fault the company for thinking outside the box here. Castagna recognizes that the word "reversed" is controversial, particularly when you have celebrities such as Halle Berry and Drew Carrie who've used that word to essentially claim erasing their disease. He says it's clear that diabetes can't be erased, and it's about educating the PWD masses on management basics. "How many shows focus on diabetes? I can't think of any," Castagna says. "We have shows focusing on plastic surgery, emergency rooms, on pain, but there's nothing out there like this to raise awareness. That's why it's important that somebody does something, and why MannKind is sponsoring this. We can debate the word 'reversed,' but I don't think that's the right debate to be having -- even though I wouldn't argue it shouldn't be used. But the debate should be why we aren't we raising awareness about achieving better health outcomes? That's what I hope comes out of the show." Meanwhile, our team is rooting for Afrezza to do well on the market; Amy and I both currently use it, so we're making no bones about the fact that we think it's a good drug that can help many PWDs. If all goes well, this show could be a win-win for everyone. We shall see... It deserves a chance, if nothing else. So keep an eye on your TV listings this summer, D-Friends.
|
|
|
Post by lakers on May 1, 2017 17:30:36 GMT -5
Andrew McMurray, MBA Regional Sales Leader - Southeast, Mannkind Corporation MannKind Corporation Franklin University Naples, Florida Area / Experience MannKind Corporation Regional Business Manager Company NameMannKind Corporation Dates EmployedFeb 2017 – Present Employment Duration4 mos SanofiArea Business Leader Company NameSanofi Dates EmployedDec 2016 – Feb 2017 Employment Duration3 mos Joseph Saldanha VP Marketing at MannKind Corporation Sanofi Aventis University of Pennsylvania Valencia, California Was Sr Dir at Sanofi/ John SliwkaVice President, Market Access and Trade at MannKind Corporation MannKind Corporation California State University, Chico El Dorado Hills, California Vice President, Market Access and Trade Company NameMannKind Corporation Dates EmployedNov 2016 – Present Employment Duration7 mos Head of Market Access and Trade reporting into Chief Commercial Officer. Responsibilities include leadership of market access and trade departments, leading value marketing, HEOR, pricing and contracting, pull through, reimbursement HUB, trade and national account director team management. / Leonard Erskine
National Account Director, U.S. Payer Access, Trade, & Specialty Distribution at MannKind Corporation MannKind Corporation The Ohio State University Cleveland/Akron, Ohio Area National Account Director, .U. S. Payer Access, Trade, & Specialty Distribution Company NameMannKind Corporation Dates EmployedJul 2016 – Present Employment Duration11 mos Building a start up company to launch first in class novel therapies in the U.S. Market Place Responsible for all Payer Channels: Commercial, PBM, Medicare Part D, Fee for Service Medicaid, Specialty Pharmacy, IDN's & Trade Distribution Lead all contract negotiations for United Health Group, Optum Rx, Humana, Aetna, CVS Caremark, Silverscripts, Magellan Health Care and Goold Health Systems
Develop key payer initiatives, strategies and innovative programs with all key stakeholders (National and Regional Health Plans) / Suzanne Hensley
National Account Director at MannKind Corporation MannKind Corporation California State University - Hayward San Francisco Bay Area National Account Director Company NameMannKind Corporation Dates EmployedJul 2016 – Present Employment Duration11 mos National Account Director for MannKind Corporation, a biopharmaceutical company responsible for the commercialization of therapeutic products across U.S. National Payers. Responsible for launching novel and innovative technology solutions to manage diabetes across all payer channels: Commercial, Health Exchange, Medicare Part D, State Medicaid, Managed Medicaid and Indian Health Services./ Todd Hamilton
Regional Business Manager at MannKind Corporation MannKind Corporation Indiana University Bloomington Greater Chicago Area / Regional Business Manager, Midwest Company NameMannKind Corporation Dates EmployedMay 2016 – Present Employment Duration1 yr 1 mo LocationGreater Chicago Area Biopharmaceutical Sales Management of a startup biopharmaceutical company for the commercialization of Afrezza. MannKind Corporation focuses on the discovery, development, and commercialization of therapeutic products for patients. • Involvement in the commercialization and product launch planning, including hiring a sales force, sales incentive compensation, sales force automation/CRM, company values and culture, new interview guide, launch strategy and tactics, and sales training. • Hired a team of 9 Area Business Managers in 4 weeks (June 2016). • Responsible for business development within a 10-state area, including KOL development, implementing speaker programs, and the deployment of resources involving reimbursement support, national accounts, and medical affairs. Stephanie Austin, MS Ed
Area Business Manager, Mannkind Corporation MannKind Corporation Old Dominion University Graduate School Norfolk, Virginia Area / Experience MannKind Corporation Area Business Manager Company NameMannKind Corporation Dates EmployedFeb 2017 – Present Employment Duration4 mos LocationVirginia Beach, Virginia Sanofi
Diabetes Senior Sales Professional
Company NameSanofi Dates EmployedAug 2013 – Jan 2017 Employment Duration3 yrs 6 mos LocationVirginia Beach, Virginia
|
|
|
Post by lakers on May 1, 2017 16:32:15 GMT -5
MannKind Corporation to Hold 2017 First Quarter Financial Results Conference Call on May 10, 2017 investors.mannkindcorp.com/releasedetail.cfm?ReleaseID=1023513VALENCIA, Calif., April 28, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) will release its 2017 first quarter financial results on Wednesday, May 10, 2017 and its management will host a conference call to discuss the first quarter financial results and other Company developments at 5:00 PM (Eastern Time) on May 10, 2017. Presenting from the Company will be its Chief Executive Officer, Matthew J. Pfeffer and other members of senior management. To view and listen to the earnings call webcast, visit the Company's website at www.mannkindcorp.com and click on the "Q1 2017 MannKind Earnings Conference Call" link in the Webcast section of News & Events. To participate in the live call by telephone, please dial (888) 771-4371 or (847) 585-4405 and use the participant passcode: 44096372. A telephone replay of the call will be accessible for approximately 14 days following completion of the call by dialing (888) 843-7419 or (630) 652-3042 and use the participant passcode: 4409 6372#. A replay will also be available on MannKind's website for 14 days.
|
|
|
Post by lakers on May 1, 2017 14:42:35 GMT -5
Schwab raised interest from 19% to 23.5%, 5/1/17. Shorts seem determined to get Pps under $1 until some news force them to cover.
|
|
|
Post by lakers on May 1, 2017 14:24:05 GMT -5
|
|
|
Post by lakers on Apr 30, 2017 4:24:28 GMT -5
At the expense of Sny.
Turning to Slide 12. Sales of our growing Diabetes franchise declined by 6% in the first quarter. This was primarily driven by a 15% decline in the U.S. business which more than offset double-digit growth in Emerging Markets.
We caution against extrapolating first quarter performance to the remaining quarters of 2017 as we expect the U.S. Diabetes sales decline to accelerate over the remainder of the year. Keep in mind that there will be an incremental effect from the CBS formulary exclusion in Q2 and the United Health formulary just went into effect on April 1. Consequently, it remains our expectation, as we said last quarter, that Diabetes performance in 2017 is highly likely to come in below our minus 4 to minus 8 midyear guidance range. Within the overall outlook for the franchise, we expect to make steady progress with the rollout of our basal insulin, GLP-1 combo product, Soliqua and you have secured efficient coverage in the U.S. in the first quarter.
|
|
|
Post by lakers on Apr 26, 2017 18:46:42 GMT -5
|
|
|
Post by lakers on Apr 26, 2017 18:43:13 GMT -5
Obtaining Afrezza & Tresiba afrezzadownunder.com/obtaining-afrezza/Each country has their own scheme for the importation of unapproved medicines. This page will be updated with links for the method in each country. You will first need to talk with your endocrinologist and get them on board. They will be very interested in your progress, as their peers have likely not even heard of Afrezza. Afrezza is very expensive to those outside the US. The only way to obtain it at the moment is from International Pharmacy. Afshin, the pharmacy owner thinks he might be able to get lower pricing if he can gain sufficient order volume. Tresiba basal insulin is available in many countries, including the US, central and South America, much of Asia and all of Europe. The cheapest way to obtain Tresiba might be to see a doctor if you are already going overseas. Alternatively, it can be imported from Victoria Pharmacy in Switzerland. When using these online pharmacies, you will need to supply a prescription or letter from your doctor with your order. The rules in most countries allow importation of a three-month supply of the medicine at a time. A prescription or letter from your doctor will be needed to be included with the shipment. In some countries, it will be needed to be sent directly to your doctor. Australia The TGA Personal Import Scheme applies to Afrezza. www.tga.gov.au/personal-importation-schemeNew Zealand The Medsafe rules on personal importation apply to Afrezza. www.medsafe.govt.nz/consumers/miet/importmedicines.aspSingapore HSA issues these guidelines for the importation of medicines such as Afrezza. www.hsa.gov.sg/content/hsa/en/Health_Products_Regulation/Consumer_Information/Personal_Import_Regulations/bringing_medical_devices_for_personal_use_into_Singapore.htmlUnited States Afrezza and Tresiba are easily obtainable in the US and are covered by many health insurers.
|
|